Climb Bio, INC. (CLYM) — DEFA14A Filings
All DEFA14A filings from Climb Bio, INC.. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (3)
- DEFA14A Filing — Apr 24, 2026
-
Climb Bio Files Supplemental Proxy for 2025 Meeting
— May 23, 2025 Risk: low
Climb Bio, Inc. (formerly Eliem Therapeutics, Inc.) is filing a supplemental proxy statement for its 2025 Annual Meeting of Stockholders. The filing, dated May -
Eliem Therapeutics Files Proxy Statement Supplement
— Jun 14, 2024 Risk: low
Eliem Therapeutics, Inc. filed a Definitive Additional Materials filing (DEFA14A) on June 14, 2024, related to its 2024 Annual Meeting of Stockholders. This fil
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX